Anzeige
Mehr »
Sonntag, 22.03.2026 - Börsentäglich über 12.000 News
Das "Next Butte?"-Setup in Montana - und es ist noch immer eine $15M-Story
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40S1S | ISIN: US1311001093 | Ticker-Symbol:
NASDAQ
20.03.26 | 20:57
1,920 US-Dollar
+4,92 % +0,090
Branche
Logistik/Transport
Aktienmarkt
Sonstige
1-Jahres-Chart
CALLAN JMB INC Chart 1 Jahr
5-Tage-Chart
CALLAN JMB INC 5-Tage-Chart

Aktuelle News zur CALLAN JMB Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.03.CALLAN JMB INC. - 8-K, Current Report2
11.03.Callan JMB to oversee manufacturing for Long COVID drug trial4
11.03.Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech's IND Clinical Trials for lodonal in the Treatment of Long COVID2
15.01.Callan JMB Shares Soar 240% On Strategic Biotech Oversight Deal2
15.01.Callan JMB signs strategic agreement with Attune Biotech2
15.01.Callan JMB Inc.: Callan JMB Signs Manufacturing Oversight, Federal Deployment, and Commercialization Agreement of Multi-Asset Therapeutic Pipeline with Attune for Approximately $50 to $75 Million in Total Revenue4
12.01.Callan JMB Inc. Announces Major Strategic Pivot to Cold-Chain Infrastructure for the $100 Billion GLP-1 Pharmaceutical Market; Initiates Retrofitting of Texas cGMP Facility571GALVESTON, TX / ACCESS Newswire / January 12, 2026 / Callan JMB Inc. (NASDAQ:CJMB), a premier provider of vertically integrated temperature-controlled logistics and specialized life sciences fulfillment...
► Artikel lesen
31.12.25CALLAN JMB INC. - 8-K, Current Report1
CALLAN JMB Aktie jetzt für 0€ handeln
08.12.25Callan JMB ändert Richtlinie für Insiderhandel und verkürzt die Sperrfrist7
05.12.25CALLAN JMB INC. - 8-K, Current Report1
14.11.25Callan JMB Inc. GAAP EPS of -$0.61, revenue of $1.44M3
14.11.25Callan JMB Inc.: Callan JMB Announces Third Quarter 2025 Financial Results and Provides Business Update1.073Expanded the Company's compliance-driven logistics platform into the food sampling industryEntered agreement to install oral drug delivery equipment at Texas facility Established a subsidiary in India...
► Artikel lesen
13.11.25Callan JMB enters agreement to host oral drug delivery manufacturing2
13.11.25Callan JMB Inc.: Callan JMB Enters Agreement to Install Oral Drug Delivery Equipment in Texas Facility4
10.11.25Callan JMB expands into food sampling logistics market1
10.11.25Callan JMB Inc.: Callan JMB Expands Logistics Platform Into Food Sampling Sector, Advancing Multi-Variant Growth Strategy3
10.11.25EXCLUSIVE: Callan JMB Teams Up With Keychain To Boost Food Sampling Compliance Services1
13.10.25Callan JMB Inc.: Callan JMB Upgrades Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring1
14.08.25Callan JMB Inc.: Callan JMB Announces Second Quarter 2025 Financial Results and Provides Business Update1.053Formed a strategic partnership with Revival Health Inc. ("Revival") to deliver fully integrated supply chain services and infrastructure to support both the importation and onshore manufacturing of...
► Artikel lesen
15.05.25Callan JMB Inc.: Callan JMB Announces First Quarter 2025 Financial Results and Provides Business Update381Completed Initial Public Offering (IPO) on February 6, 2025, at $4.00 per Share for Gross Proceeds of Approximately $5.7 Million, Including Partial Exercise of Over-Allotment Option SPRING BRANCH...
► Artikel lesen
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1